Systematic comparison of experimental assays and analytical pipelines for identification of active enhancers genome-wide
Yao LiiD, Jin Hua LiangiD, Abdullah OzeriD, Alden King-Yung LeungiD, John T. LisiD, Haiyuan YuiD
Abstract
Mounting evidence supports the idea that transcriptional patterns serve as more specific identifiers of active enhancers than histone marks1,2; however, the optimal strategy to identify active enhancers both experimentally and computationally has not been determined. In this study, we compared 13 genome-wide RNA sequencing assays in K562 cells and showed that the nuclear run-on followed by cap-selection assay (namely, GRO/PRO-cap) has significant advantages in eRNA detection and active enhancer identification. We also introduced a new analytical tool, Peak Identifier for Nascent-Transcript Sequencing (PINTS), to identify active promoters and enhancers genome-wide and pinpoint the precise location of the 5 transcription start sites (TSSs) within these regulatory elements. Finally, we compiled a comprehensive enhancer candidate compendium based on the detected eRNA TSSs available in 120 cell and tissue types. To facilitate the exploration and prioritization of these enhancer candidates, we also built a user-friendly web server (https://pints.yulab.org) for the compendium with various additional genomic and epigenomic annotations. With the knowledge of the best available assays and pipelines, this large-scale annotation of candidate enhancers will pave the road for selection and characterization of their functions in a time-, labor-, and cost-effective manner in the future.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 89
- FWCI
- 5.63
- Field percentile
- top 2%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Reporter gene assays and chromatin-level assays define substantially non-overlapping sets of enhancer sequences
Daniel Lindhorst, Marc S. Halfon·BMC GenomicsPeer-reviewed·Jan 13, 2023
- Uncovering Hidden Enhancers Through Unbiased In Vivo Testing
Brandon J. Mannion, Stella Tran, … Len A. Pennacchio·Nature CommunicationsPeer-reviewed·Aug 7, 2025
- Comprehensive Evaluation of Diverse Massively Parallel Reporter Assays to Functionally Characterize Human Enhancers Genome-wide
Junke Zhang, Alden King-Yung Leung, … Haiyuan Yu·Genome biologyPeer-reviewed·Nov 3, 2025
- Start from Scratch: Precisely Identify Massive Active Enhancers by Sequencing
Xiusheng Zhu, Lei Huang, … Yubo Zhang·bioRxiv·Apr 10, 2019
- Capped nascent RNA sequencing reveals novel therapy-responsive enhancers in prostate cancer
Kellie A. Cotter, Sagar R. Shah, … Haiyuan Yu·bioRxiv·Apr 8, 2022
- A semi-supervised approach uncovers thousands of intragenic enhancers differentially activated in human cells
Juan Gonzalez-Vallinas, Amadís Pagès, … Eduardo Eyras·bioRxiv·Jun 3, 2015